- Dr. Godino Cosmo
- Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.
Website | E-mail
- Dr. Andrea Scotti
- Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy.
Special Issue Introduction
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered by clinicians. From the Framingham Heart Study it was estimated the risk of developing AF that, from age 40 to age 95, was 26 percent for men and 23 percent for women. The prevalence of AF is even greater in the presence of valvular heart disease that is an established risk factor for the occurrence of this arrhythmia. As well as being common, AF has a detrimental impact on outcome (mortality, heart failure, hospitalization, and thromboembolic events), and its clinical relevance becomes even more crucial when AF is associated with structural heart disease and coronary syndromes.
Given the scale of the problem, medical companies have worked to develop devices that meet the needs of these patients. Indeed, one of the priorities was to facilitate the management of patients at high bleeding risk needing an anticoagulation therapy. At the same time, scientific societies have also had to draw up specific guidelines and recommendations concerning this population.
The overall aim of this Special Issue is to present and discuss the impact and the management of patients with AF undergoing coronary and structural heart interventions.
1. Impact of Atrial Fibrillation on patients undergoing Percutaneous Mitral Valve Repair
2. Left Atrial Appendage Occlusion in patients with Atrial Fibrillation and Left Atrial Appendage Thrombus
3. Impact of device thrombosis after Percutaneous Left Atrial Appendage Occlusion in patients with Atrial Fibrillation
4. Safety and Efficacy of Left atrial appendage occlusion in patients with Atrial Fibrillation
5. Safety and Efficacy of Electrical Isolation of the Left Atrial Appendage in patients with Atrial Fibrillation
6. Indications and Patients selection of Thoracoscopic Left Atrial Appendage Occlusion for Atrial Fibrillation
7. Atrial Fibrillation occurrence after Patent Foramen Ovale Closure
8. Impact of Valvular vs. Non valvular Atrial Fibrillation on Outcomes after Transcatheter Aortic Valve Replacement
9. Impact of New-Onset Atrial Fibrillation on Outcomes after Transcatheter Aortic Valve Replacement
10. New-Onset Atrial Fibrillation after Percutaneous Coronary Intervention for Acute Coronary Syndromes
11. Risk of Stent Thrombosis in patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention
12. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Where Are We Now and were are we going?
13. Current Indications and Patients selection for Epicardial Radiofrequency Ablation of Atrial Fibrillation
14. Catheter Ablation for Atrial Fibrillation: Current Status and Glimpse to the future
15. Atrial Functional Mitral Regurgitation: mechanisms and implications for surgical and percutaneous repair
Submission Deadline 1 Jul 2022